About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  QUARTERLY RESULTS
Quarterly Results      
Emcure Pharmaceuticals Ltd.
BSE Code 544210
ISIN Demat INE168P01015
Book Value 169.51
NSE Code EMCURE
Dividend Yield % 0.21
Market Cap 272897.55
P/E 63.44
EPS 22.69
Face Value 10  
Quarters :
(Rs. in Millions)
Particulars (Rs in Million) Sep 2025Jun 2025Mar 2025Dec 2024
 Audited / UnAudited UnAudited UnAudited UnAudited UnAudited
Net Sales 12606.04 10965.73 12781.88 10288.13
Total Expenditure 10653.99 8685.73 10335.51 9043.96
PBIDT (Excl OI) 1952.05 2280.00 2446.37 1244.17
Other Income 521.39 215.24 223.96 194.10
Operating Profit 2473.44 2495.24 2670.33 1438.27
Interest 277.14 205.38 240.69 199.29
Exceptional Items 0 -35.00 0 0
PBDT 2196.30 2254.86 2429.64 1238.98
Depreciation 617.39 598.17 569.12 566.46
Profit Before Tax 1578.91 1656.69 1860.52 672.52
Tax 402.69 428.80 464.95 170.48
Provisions and contingencies 0 0 0 0
Profit After Tax 1176.22 1227.89 1395.57 502.04
Extraordinary Items 0 0 0 0
Prior Period Expenses 0 0 0 0
Other Adjustments 0.00 0.00 0.00 0.00
Net Profit 1176.22 1227.89 1395.57 502.04
Equity Capital 1895.65 1895.08 1894.83 1894.32
Face Value (IN RS) 10 10 10 10
Reserves    
Calculated EPS 6.20 6.48 7.37 2.65
Calculated EPS (Annualised) 24.82 25.92 29.46 10.60
No of Public Share Holdings 41923389.00 41859065.00 41834065.00 41782565.00
% of Public Share Holdings 22.12 22.09 22.08 22.06
     
PBIDTM% (Excl OI) 15.49 20.79 19.14 12.09
PBIDTM% 19.62 22.75 20.89 13.98
PBDTM% 17.42 20.56 19.01 12.04
PBTM% 12.53 15.11 14.56 6.54
PATM% 9.33 11.20 10.92 4.88
 Notes Notes Notes Notes
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.